ArticleJournal of clinical biochemistry and nutrition2017
Effects of patient age and choice of antisecretory agent on success of eradication therapy for
Article in Journal of clinical biochemistry and nutrition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 36 citations in OpenAlex.
- Vonoprazan a novel potassium competitive acid blocker; another leap forward.Przeglad gastroenterologiczny · 2024Article
- Novel therapeutic regimens againstFrontiers in microbiology · 2024Review
- Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis.Therapeutic advances in gastroenterology · 2023Article
- Increasing trend ofJournal of clinical biochemistry and nutrition · 2022Article
- Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms ofGut and liver · 2021Review
- Efficacy of Seven-Day Potassium-Competitive Acid Blocker-Based First-LineYonsei medical journal · 2021Article
- The simplified Kyoto classification score is consistent with the ABC method of classification as a grading system for endoscopic gastritis.Journal of clinical biochemistry and nutrition · 2021Article
- A single nucleotide polymorphism inJournal of clinical biochemistry and nutrition · 2021Article
- Article
- The Potential Benefits of Vonoprazan asPharmaceuticals (Basel, Switzerland) · 2020Review
- Clinical factors associated with initial Helicobacter pylori eradication therapy: a retrospective study in China.Scientific reports · 2020Article
- Current status ofWorld journal of gastroenterology · 2020Article
- Efficacy of Vonoprazan for Helicobacter pylori Eradication.Internal medicine (Tokyo, Japan) · 2020Review
- Adverse events associated with bidirectional endoscopy with midazolam and pethidine.Journal of clinical biochemistry and nutrition · 2020Article
- A combination of serum anti-United European gastroenterology journal · 2019Article
- Evaluation of gastric acid suppression with vonoprazan using calcium carbonate breath test.Journal of clinical biochemistry and nutrition · 2019Article
- Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker.Journal of neurogastroenterology and motility · 2019Review
- Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori.Cancers · 2019Article
- Current status of first- and second-lineTherapeutic advances in gastroenterology · 2019Article
- Pethidine dose and female sex as risk factors for nausea after esophagogastroduodenoscopy.Journal of clinical biochemistry and nutrition · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The effects of patient age on the efficacy of eradication treatment for
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.